When a customer submits an Environmental Protection Agency Toxic Substances Control Act Section 8(e) substantial-risk notice under 15 U.S.C. § 2607(e) that names your product among the analytical methods, sampling instruments, exposure-modeling platforms, or risk-evaluation tools used in the substantial-risk determination, supports a Chemical Data Reporting (CDR) submission under 40 C.F.R. Part 711 that names your product as part of the production-volume reporting or processing-and-use characterization, or contributes to a TSCA Section 4 test-rule response under 15 U.S.C. § 2603 that names your product as part of the test-protocol execution or data-quality-objective satisfaction, and the Section 8(e) substantial-risk notice narrative, the CDR submission filing, or the Section 4 test-rule response document names your product as part of the customer's chemical-substance safety review, they have left a category of endorsement that almost no marketing-elicited testimonial can replicate. The Section 8(e) notice has been filed under the substantial-risk reporting commitment of the Toxic Substances Control Act of 1976 as amended by the Frank R. Lautenberg Chemical Safety for the 21st Century Act of 2016, archived permanently in the EPA's ChemView public chemical-substance-information portal and the EPA TSCA docket public-record system where any future chemical-manufacturer, regulator, downstream-formulator compliance team, or competing supplier can retrieve it, scrutinized by independent EPA Office of Chemical Safety and Pollution Prevention (OCSPP) reviewers and Office of Pollution Prevention and Toxics (OPPT) risk-assessment staff who have direct statutory incentives to dispute any inaccuracy, and frequently re-referenced in subsequent TSCA Section 6 risk-management rulemakings, Section 5 premanufacture-notice reviews, and Section 8(a) preliminary-assessment-information determinations for years after the original filing. The Section 8(e) notice carries the chemical-substance-manufacturer's safety-data testimony, the EPA ChemView archive carries the regulatorily-ratified public-availability, and the surrounding context establishes that the notice was filed under one of the most procedurally constrained chemical-substance-safety-regulatory environments any chemical manufacturer or downstream processor faces.
Almost no chemical-analytical-instrument supplier, exposure-modeling-software vendor, risk-assessment-platform provider, or chemical-data-management-platform vendor systematically extracts product mentions from public EPA TSCA Section 8(e) substantial-risk notice and Chemical Data Reporting archives. The omission is the natural extension of the same blind spots we documented in our CPSC Section 15(b) report extraction guide, our NRC licensee event report extraction guide, our NHTSA vehicle safety recall extraction guide, and our FDA 510(k) extraction guide. Consumer-product safety covers distributor-attested Section 15(b) mentions. Nuclear safety covers operator-attested licensee-event mentions. Automotive recall covers vehicle-defect-investigation mentions. Medical device regulatory disclosures cover premarket-notification mentions. EPA TSCA Section 8(e) substantial-risk notices and CDR submissions cover chemical-manufacturer-attested, EPA-archive-permanent, ChemView-cross-indexed, OECD-Mutual-Acceptance-of-Data-bound, Lautenberg-Act-strengthened product mentions made under the most procedurally constrained chemical-substance-safety-regulatory environment any chemical manufacturer or downstream formulator publishes into — a pillar of the structurally durable public corpus that no other extraction surface can replicate, and the only one where the customer's testimony has been tied specifically to a substantial-risk determination that the chemical-substance-safety community depends on as the operative trigger for its own risk-management and downstream-use decisions.
This guide describes the extraction workflow for the EPA TSCA Section 8(e) substantial-risk notice and CDR submission corpus.
Why an EPA TSCA Section 8(e) substantial-risk notice mention beats almost every marketing-elicited testimonial
An EPA TSCA Section 8(e) substantial-risk notice mention is a category of endorsement that has passed through filters no marketing-elicited testimonial encounters. Six properties stack to make it one of the most adversarially credible chemical-substance-safety endorsement formats in modern B2B marketing.
First, the entry has been filed under a reporting framework that the customer has committed to follow as a regulatory obligation backed by civil-penalty exposure. EPA TSCA Section 8(e) notices are governed by the substantial-risk reporting requirements of 15 U.S.C. § 2607(e) (the immediate-reporting obligation for information reasonably supporting a conclusion that a chemical substance or mixture presents a substantial risk of injury to health or the environment), 15 U.S.C. § 2615 (the civil-penalty and criminal-penalty provision providing civil penalties up to $37,500 per day per violation as of EPA's most recent inflation adjustment), and the TSCA Compliance Audit Program clemency framework. A product mention in a Section 8(e) notice is being made under a reporting commitment that the customer has accepted as a binding statutory obligation backed by daily-accrual civil-penalty exposure and TSCA Section 16 criminal-penalty exposure. The reporting-commitment property is what makes Section 8(e) mentions more credible than mentions in any format that does not pass through a comparable statutory-obligation framework.
Second, the entry is archived permanently in the EPA ChemView portal, the TSCA docket public-record system, and the OECD eChemPortal cross-jurisdictional archive. EPA TSCA Section 8(e) notices, CDR submissions, and Section 4 test-rule responses are preserved indefinitely in the EPA ChemView public chemical-substance-information portal at chemview.epa.gov, cross-indexed in the TSCA docket public-record system that EPA maintains at regulations.gov under docket prefix EPA-HQ-OPPT, mirrored in the OECD eChemPortal cross-jurisdictional chemical-substance-information archive that the OECD Mutual Acceptance of Data framework supports, and referenced in EPA OPPT risk-evaluation document archives that document the agency's TSCA Section 6 risk-management framework. A product mention in a Section 8(e) notice is therefore preserved across at least four independent public-record archives where the notice can be retrieved by any party with an interest in the chemical substance, the manufacturer, or the downstream-use chain. The four-archive-permanence property is what makes Section 8(e) mentions more durable than mentions in any format without comparable multi-archive preservation.
Third, the entry has been scrutinized by EPA OCSPP reviewers, OPPT risk-assessment staff, and the TSCA Section 6 risk-evaluation program. EPA's Office of Chemical Safety and Pollution Prevention reviews each Section 8(e) notice for risk-significance and identifies follow-up risk-evaluation prioritization under the TSCA Section 6(b) prioritization framework, and the Office of Pollution Prevention and Toxics reviews substantial-risk findings for Section 6(b) risk-management-rule implications. A product mention in a Section 8(e) notice is being read by EPA OCSPP reviewers and OPPT risk-assessment staff who have direct statutory knowledge of the substantial-risk framework and an incentive to surface any inaccuracy that would affect the risk-management-rule disposition or the risk-evaluation prioritization. The independent-EPA-reviewer-scrutiny property is what makes Section 8(e) mentions more adversarially tested than mentions in any format without comparable chemical-substance-safety-community exposure.
Fourth, the entry is anchored to a specific TSCA submission number and ChemView record identifier. EPA TSCA Section 8(e) notices are identified by a unique 8EHQ-prefix submission number assigned at receipt and are tied to a specific ChemView record-identifier that triggers the public-availability cycle, the cross-jurisdictional notification cycle, and the downstream-formulator awareness cycle. A product mention in a Section 8(e) notice therefore inherits a submission-number-and-record-identifier-anchored authority that establishes the mention was filed at a precise, immutable point in the chemical-substance manufacturer's safety-reporting history. The submission-number-anchor property is materially stronger than the equivalent on any format without comparable immutable-identifier coverage.
Fifth, the entry is cross-referenced by downstream-formulator safety-data-sheet systems, chemical-trade-association compliance archives, and tort-litigation chemical-exposure discovery. The downstream-formulator safety-data-sheet (SDS) systems that the OSHA Hazard Communication Standard (29 C.F.R. § 1910.1200) requires routinely cross-reference TSCA Section 8(e) notices as the operative basis for the Section 11 health-hazard classification, the chemical-trade-association compliance archives that the American Chemistry Council, the Society of Chemical Manufacturers and Affiliates, and the Independent Lubricant Manufacturers Association maintain routinely cross-reference Section 8(e) findings as evidentiary basis for industry-stewardship advocacy, and the tort-litigation chemical-exposure discovery archives that plaintiff-side toxic-tort counsel maintain routinely cross-reference Section 8(e) notices as the foundation for product-identification and exposure-pathway proof. A product mention in a Section 8(e) notice therefore inherits a cross-reference network that establishes the mention's authority at the highest level of chemical-substance-safety, downstream-formulator-stewardship, and tort-litigation analysis. The cross-reference property is what makes Section 8(e) mentions more authority-anchored than mentions in any format without comparable multi-stakeholder cross-reference coverage.
Sixth, the entry is frequently re-referenced in subsequent TSCA Section 6 risk-management rulemakings, Section 5 premanufacture-notice reviews, and Section 8(a) preliminary-assessment-information determinations. Subsequent TSCA Section 6 risk-evaluations under 15 U.S.C. § 2605, Section 5 premanufacture-notice (PMN) reviews under 15 U.S.C. § 2604, Section 8(a) preliminary-assessment-information rules under 15 U.S.C. § 2607(a), and Section 4 test-rule promulgations under 15 U.S.C. § 2603 routinely re-reference prior Section 8(e) notices as the substantial-risk-history basis. A product mention in a Section 8(e) notice is therefore not a one-time disclosure but a foundation for subsequent regulatory artifacts that compound the original endorsement across multiple TSCA regulatory cycles. The re-reference property is what makes Section 8(e) mentions more durable than mentions in any format without comparable cross-regulatory-cycle compounding.
The seven Section 8(e) notice locations where customer mentions appear
The EPA TSCA Section 8(e) substantial-risk notice and CDR submission ecosystem has seven primary content locations where a product mention can surface, and each carries a different credibility weight and a different downstream usability.
Location 1 — The substantial-risk-information narrative where your customer names your product as part of the analytical or exposure-assessment method
A substantial-risk-information narrative section that names the vendor product as part of the analytical method or exposure-assessment characterization is the highest credibility-dense location because the substantial-risk-information narrative is the central reasoning of the Section 8(e) notice and the customer is publicly attesting that the vendor product was a component of the analytical or assessment method at the time the substantial-risk determination was made. The substantial-risk-narrative format is the highest-weight format for Section 8(e) extraction.
Location 2 — The supporting-study summary where your customer credits your product as part of the study-execution protocol
A supporting-study summary that credits the vendor product as part of the study-execution protocol — for example, where the supporting study cites a vendor-supplied analytical instrument identifier, a vendor-supplied test-protocol guideline reference, or a vendor-supplied data-acquisition platform — is the second-highest credibility-dense location because the supporting-study summary is the evidentiary-foundation section that the EPA risk-assessment staff relies on to evaluate the substantial-risk determination's reproducibility. The supporting-study format is a high-weight format for Section 8(e) extraction.
Location 3 — The exposure-pathway characterization where your customer credits your product as part of the pathway modeling
An exposure-pathway characterization that credits the vendor product as part of the pathway modeling — for example, where the exposure-pathway analysis cites a vendor-supplied dispersion-modeling platform, a vendor-supplied multimedia-fate-and-transport model, or a vendor-supplied bioaccumulation-prediction tool — is a high credibility-dense location because the exposure-pathway characterization is the analytical-content section that the EPA OPPT staff relies on to evaluate the substantial-risk determination's exposure-realism. The exposure-pathway format is a high-weight format for Section 8(e) extraction.
Location 4 — The hazard-identification section where your customer attributes the toxicity-data interpretation to your product
A hazard-identification section that attributes the toxicity-data interpretation to the vendor product — for example, where the hazard identification cites a vendor-supplied toxicology-database reference, a vendor-supplied structure-activity-relationship prediction platform, or a vendor-supplied read-across-justification framework — is a high credibility-dense location because the hazard-identification section is the substantive analytical content that the EPA risk-assessment staff relies on to evaluate the substantial-risk determination's hazard-characterization adequacy. The hazard-identification format is a high-weight format for Section 8(e) extraction.
Location 5 — The CDR submission processing-and-use narrative where your customer names your product as part of the use-volume characterization
A Chemical Data Reporting (CDR) submission processing-and-use narrative that names the vendor product as part of the use-volume characterization — for example, where the CDR submission cites a vendor-supplied production-volume tracking system, a vendor-supplied downstream-use-monitoring platform, or a vendor-supplied data-aggregation tool — is a medium-to-high credibility-dense location because the CDR submission is a separate TSCA reporting cycle under 40 C.F.R. Part 711 that captures production-volume and processing-and-use information at four-year intervals. The CDR processing-and-use format is a medium-to-high-weight format for Section 8(e) extraction.
Location 6 — The Section 4 test-rule response where your customer credits your product as part of the test-protocol execution
A TSCA Section 4 test-rule response that credits the vendor product as part of the test-protocol execution — for example, where the test-rule response cites a vendor-supplied OECD test-guideline-compliant analytical method, a vendor-supplied Good Laboratory Practice (GLP) data-acquisition platform, or a vendor-supplied Mutual Acceptance of Data (MAD) qualifying instrument — is a medium-to-high credibility-dense location because the Section 4 test-rule response is a separate TSCA Section 4 reporting cycle that captures hazard-data-development information in response to an EPA-issued test rule. The Section 4 test-rule format is a medium-to-high-weight format for Section 8(e) extraction.
Location 7 — The pre-manufacture notice (PMN) supporting documentation where your customer credits your product as part of the new-chemical characterization
A TSCA Section 5 pre-manufacture notice (PMN) supporting documentation section that credits the vendor product as part of the new-chemical characterization — for example, where the PMN supporting documentation cites a vendor-supplied characterization method, a vendor-supplied physicochemical-property determination instrument, or a vendor-supplied structure-elucidation platform — is a medium credibility-dense location because the PMN is a separate TSCA Section 5 reporting cycle that captures new-chemical-substance information ninety days before manufacture or import. The PMN supporting-documentation format is a medium-weight format for Section 8(e) extraction.
How to extract Section 8(e) notice mentions from the EPA ChemView and TSCA docket archives
The extraction workflow for the EPA TSCA Section 8(e) substantial-risk notice and CDR submission corpus follows four phases — discovery, retrieval, normalization, and testimonial-format conversion.
The discovery phase uses the EPA ChemView search interface at chemview.epa.gov, the EPA TSCA docket public-record system at regulations.gov filtered by docket prefix EPA-HQ-OPPT, and the OECD eChemPortal cross-jurisdictional chemical-substance-information archive at echemportal.org. The discovery query combines the chemical substance's Chemical Abstracts Service (CAS) Registry Number, the manufacturer's company-identifier (the EPA-assigned company-identifier or the Dun & Bradstreet number), and the vendor product's brand-identifier or technical-identifier. Discovery returns a candidate set of Section 8(e) submission numbers, CDR submission identifiers, and Section 4 test-rule response identifiers.
The retrieval phase retrieves the full text of each candidate submission. EPA ChemView publishes the substantial-risk-information narrative in HTML and PDF format with a structured metadata header that includes the submission date, the chemical-substance CAS Registry Number, the manufacturer-identifier, and the substantial-risk-determination disposition. The TSCA docket public-record system publishes the supporting-study summaries, the exposure-pathway characterizations, the hazard-identification sections, and the supplementary correspondence. Retrieval normalizes the candidate set into a corpus of structured Section 8(e) records.
The normalization phase parses each Section 8(e) record into seven structured sub-records corresponding to the seven content locations described above — the substantial-risk-information narrative, the supporting-study summary, the exposure-pathway characterization, the hazard-identification section, the CDR processing-and-use narrative, the Section 4 test-rule response, and the PMN supporting-documentation section. Each sub-record is tagged with the vendor-product mention if present, the mention type (analytical method, exposure model, hazard-data platform), and the credibility weight derived from the location-and-property-stack mapping.
The testimonial-format conversion phase transforms each tagged mention into a deployable testimonial format. The output formats include a short-quote attribution citation (CAS number, submission number, submission date), a long-form narrative summary (the substantial-risk context, the vendor-product role, the regulatory disposition), and a hyperlinked testimonial card (linking to the ChemView record and the TSCA docket entry). Each output format includes a structured-metadata header that downstream marketing-automation platforms can ingest.
Operational considerations for the extraction workflow
The Section 8(e) extraction workflow is bound by three operational considerations that distinguish it from the marketing-elicited testimonial workflow.
The first consideration is the confidentiality-business-information (CBI) claim. TSCA Section 14 permits manufacturers to assert CBI claims over portions of Section 8(e) notices, CDR submissions, and PMN filings. The extraction workflow must respect CBI redactions in the public-record archive and treat redacted text as unavailable for extraction. The structural reader who tags the CBI-redaction marker ("information claimed as CBI", "redacted CBI") in the candidate retrieval step avoids accidentally extracting redaction-bracketed text as a quotable mention.
The second consideration is the chemical-substance-identity-confidentiality regime. Under TSCA Section 8(b) and the Lautenberg Act, EPA maintains the TSCA Inventory in two parts — the public portion and the confidential portion. Substances on the confidential portion are identified by a generic chemical-substance-identifier (a structurally generic name and a non-specific CAS Registry Number assignment) rather than the specific CAS Registry Number. The extraction workflow must distinguish public-portion and confidential-portion substances and adjust the mention-attribution citation accordingly.
The third consideration is the OECD Mutual Acceptance of Data (MAD) cross-jurisdictional usability. Section 8(e) supporting studies that comply with OECD Good Laboratory Practice (GLP) requirements and OECD test guidelines qualify for cross-jurisdictional acceptance under the OECD MAD framework. The extraction workflow can flag MAD-qualifying mentions for higher credibility weight because the underlying study has been pre-validated for cross-jurisdictional regulatory acceptance.
Connecting Section 8(e) extraction to the public-archive testimonial portfolio
The Section 8(e) substantial-risk notice extraction workflow joins the public-archive testimonial portfolio alongside our CPSC Section 15(b) extraction workflow, our NRC licensee event report extraction workflow, our NHTSA vehicle safety recall extraction workflow, and our FDA 510(k) extraction workflow. Each extraction surface covers a specific regulatory regime and a specific category of customer-attested product mention.
The portfolio approach is what distinguishes the structural-extraction methodology from the marketing-elicited testimonial methodology. Marketing-elicited testimonials depend on customer-relations rapport and quid-pro-quo exchange. Structural-extraction testimonials depend on the customer's prior regulatory commitment to a public-record disclosure. The structural-extraction surface is wider, the credibility weight is higher, and the durability is longer.
The customer who files a Section 8(e) substantial-risk notice naming the vendor product as part of the analytical, sampling, or risk-evaluation method has produced a testimonial that no marketing-elicited solicitation could match — and the vendor who deploys the structural-extraction workflow harvests an endorsement asset that compounds across each subsequent TSCA regulatory cycle for the lifetime of the chemical-substance-safety review.